C WorldWide Group Holding A/S - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
C WorldWide Group Holding A/S ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$607,000
+5.4%
17,3250.0%0.01%0.0%
Q4 2018$576,000
-51.3%
17,325
-26.2%
0.01%
-46.7%
Q3 2018$1,182,000
-29.6%
23,473
-16.3%
0.02%
-34.8%
Q2 2018$1,679,000
-3.5%
28,058
-26.1%
0.02%
-14.8%
Q1 2018$1,739,000
-33.5%
37,966
-42.1%
0.03%
-28.9%
Q4 2017$2,614,000
-8.2%
65,600
-7.8%
0.04%
-5.0%
Q3 2017$2,846,000
-7.9%
71,143
-0.7%
0.04%
-14.9%
Q2 2017$3,089,000
-27.6%
71,670
-47.4%
0.05%
-34.7%
Q1 2017$4,265,000
+64.0%
136,272
+32.3%
0.07%
+44.0%
Q4 2016$2,601,000
-14.5%
103,000
-16.3%
0.05%
-7.4%
Q3 2016$3,042,000
+21.4%
123,0000.0%0.05%
+12.5%
Q2 2016$2,506,000
-31.0%
123,000
-48.3%
0.05%
-31.4%
Q1 2016$3,630,000
+13.5%
238,0000.0%0.07%
+25.0%
Q4 2015$3,199,000
-21.4%
238,000
-17.9%
0.06%
-17.6%
Q3 2015$4,069,000
-58.7%
290,000
-50.0%
0.07%
-2.9%
Q2 2015$9,848,000
+114.4%
580,000
+52.6%
0.07%
+6.1%
Q1 2015$4,594,000
+325.8%
380,000
+192.3%
0.07%
+312.5%
Q4 2014$1,079,000130,0000.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders